Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2756 results

Press release / Dec 09, 2025

Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses

Ianalumab (9 mg/kg) plus eltrombopag extended ITP disease control by 45% with patients maintaining disease control 2.8 times longer than with placebo plus eltrombopag1,2 62% of patients treated with…
Clinical Trials / Dec 12, 2025

A Study of DII235 in Adults With Elevated Lipoprotein(a)
Clinical Trials / Dec 11, 2025

Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Clinical Trials / Dec 05, 2025

Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients
Clinical Trials / Dec 05, 2025

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Clinical Trials / Dec 08, 2025

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
Clinical Trials / Dec 04, 2025

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Clinical Trials / Dec 03, 2025

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Clinical Trials / Dec 02, 2025

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
Clinical Trials / Dec 02, 2025

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)